Hyo-rak Lee
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Comparative Analysis of Primary and Second Primary Multiple Myeloma: A Propensity Score-Matched Study.
Journal: Clinical Medicine Insights. Oncology
Published: April 30, 2025
Therapy-related myeloid neoplasms in Korean patients with ovarian or primary peritoneal cancer treated with poly(ADP-ribose) polymerase inhibitors.
Journal: Translational cancer research
Published: July 03, 2024
Secondary hematological malignancies in patients with sarcoma: A single‑center retrospective study.
Journal: Oncology letters
Published: November 10, 2023
A Phase II Study of 131I-rituximab for Patients With Relapsed or Refractory Marginal Zone Lymphoma.
Journal: Clinical Medicine Insights. Oncology
Published: August 30, 2023
Radioimmunotherapy with 131 I-rituximab for patients with relapsed or refractory follicular or mantle cell lymphoma.
Journal: Asia-Pacific journal of clinical oncology
Published: November 02, 2022
Association of EGFR mutations in second primary lung cancer and HER2 expression in breast cancer survivors.
Journal: Translational cancer research
Published: July 09, 2021
A phase II trial of modified FOLFOX6 as first-line therapy for adenocarcinoma of an unknown primary site.
Journal: Cancer chemotherapy and pharmacology
Published: September 15, 2015
Prevalent factor XII deficiency in cancer patients with isolated aPTT prolongation.
Journal: Blood research
Published: November 10, 2014
Clinical characteristics and outcomes of primary bone lymphoma in Korea.
Journal: The Korean journal of hematology
Published: July 11, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026